These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 25263445)

  • 1. NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation.
    Licciardello MP; Müllner MK; Dürnberger G; Kerzendorfer C; Boidol B; Trefzer C; Sdelci S; Berg T; Penz T; Schuster M; Bock C; Kralovics R; Superti-Furga G; Colinge J; Nijman SM; Kubicek S
    Oncogene; 2015 Jul; 34(29):3780-90. PubMed ID: 25263445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginkgoic acid impedes gastric cancer cell proliferation, migration and EMT through inhibiting the SUMOylation of IGF-1R.
    Liu D; Li Z; Yang Z; Ma J; Mai S
    Chem Biol Interact; 2021 Mar; 337():109394. PubMed ID: 33508304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
    J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
    Biederstädt A; Hassan Z; Schneeweis C; Schick M; Schneider L; Muckenhuber A; Hong Y; Siegers G; Nilsson L; Wirth M; Dantes Z; Steiger K; Schunck K; Langston S; Lenhof HP; Coluccio A; Orben F; Slawska J; Scherger A; Saur D; Müller S; Rad R; Weichert W; Nilsson J; Reichert M; Schneider G; Keller U
    Gut; 2020 Aug; 69(8):1472-1482. PubMed ID: 32001555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumoylation dynamics during keratinocyte differentiation.
    Deyrieux AF; Rosas-Acosta G; Ozbun MA; Wilson VG
    J Cell Sci; 2007 Jan; 120(Pt 1):125-36. PubMed ID: 17164289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO pathway components as possible cancer biomarkers.
    Mattoscio D; Chiocca S
    Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
    Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
    Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
    Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
    Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the interactions of HIV-1 integrase with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
    Li Z; Wu S; Wang J; Li W; Lin Y; Ji C; Xue J; Chen J
    Int J Mol Med; 2012 Nov; 30(5):1053-60. PubMed ID: 22895527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small ubiquitin-like modifier (SUMO) modification of E1 Cys domain inhibits E1 Cys domain enzymatic activity.
    Truong K; Lee TD; Chen Y
    J Biol Chem; 2012 May; 287(19):15154-63. PubMed ID: 22403398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ang II Promotes SUMO2/3 Modification of RhoGDI1 Through Aos1 and Uba2 Subunits, and then Regulates RhoGDI1 Stability and Cell Proliferation.
    Qi Y; Guan H; Liang X; Sun J; Yao W
    Cardiovasc Drugs Ther; 2021 Aug; 35(4):769-773. PubMed ID: 33891248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectomycin B1 as a novel SUMOylation inhibitor that directly binds to SUMO E2.
    Hirohama M; Kumar A; Fukuda I; Matsuoka S; Igarashi Y; Saitoh H; Takagi M; Shin-ya K; Honda K; Kondoh Y; Saito T; Nakao Y; Osada H; Zhang KY; Yoshida M; Ito A
    ACS Chem Biol; 2013 Dec; 8(12):2635-42. PubMed ID: 24143955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sumoylation of human argonaute 2 at lysine-402 regulates its stability.
    Sahin U; Lapaquette P; Andrieux A; Faure G; Dejean A
    PLoS One; 2014; 9(7):e102957. PubMed ID: 25036361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Starting and stopping SUMOylation. What regulates the regulator?
    Watts FZ
    Chromosoma; 2013 Dec; 122(6):451-63. PubMed ID: 23812602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting SUMO Signaling to Wrestle Cancer.
    Kroonen JS; Vertegaal ACO
    Trends Cancer; 2021 Jun; 7(6):496-510. PubMed ID: 33353838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells.
    Salahuddin S; Fath EK; Biel N; Ray A; Moss CR; Patel A; Patel S; Hilding L; Varn M; Ross T; Cramblet WT; Lowrey A; Pagano JS; Shackelford J; Bentz GL
    Sci Rep; 2019 Jan; 9(1):208. PubMed ID: 30659232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.